Product Code: ETC095803 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
India Erythromycin Marketis expected to grow at a CAGR of around 8.9%.The major growth drivers are the rising prevalence of bacterial infections, increasing number of clinical trials for antibiotic drugs, and rising demand from pharmaceutical industry for new and improved antibiotics. Moreover, government initiatives such as Make in India program have led to an increased focus on developing innovative drugs which would further propel the market in coming years.
India Erythromycin Market drivers include the increasing prevalence of bacterial infections, growing geriatric population, rising healthcare expenditure and growing awareness about antibiotics. Furthermore, the introduction of new molecules in erythromycin is also expected to drive market growth. The other factors driving India erythromycin market are favorable government initiatives for antibiotic research and development, increasing number of pharmaceutical companies involved in the production of this drug as well as its easy availability through both offline and online channels. However, there are certain restraints on the market such as stringent regulations imposed by regulatory bodies across different countries with respect to erythromycin drugs??? quality control standards and pricing policies that may limit sales of these products in near future.
However, there are certain challenges that can hamper the market growth such as stringent regulations related to drug approval process and patent expiry issues leading to reduced prices. Factors like high cost of manufacturing will also affect the market growth negatively over forecast period.
Some key players operating in India erythromycin market include Zydus Cadila Healthcare Ltd., Grifols S A/Grifols India Pvt Ltd., Sanofi-Aventis Pharmaceuticals India Pvt Ltd., Unichem Laboratories Limited, Merck Sharp & Dohme (MSD) Pharmaceuticals Private Limited among others
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Erythromycin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Erythromycin Market Revenues & Volume, 2021 & 2031F |
3.3 India Erythromycin Market - Industry Life Cycle |
3.4 India Erythromycin Market - Porter's Five Forces |
3.5 India Erythromycin Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.6 India Erythromycin Market Revenues & Volume Share, By Therapeutic Indications, 2021 & 2031F |
3.7 India Erythromycin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Erythromycin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Erythromycin Market Trends |
6 India Erythromycin Market, By Types |
6.1 India Erythromycin Market, By Formulation |
6.1.1 Overview and Analysis |
6.1.2 India Erythromycin Market Revenues & Volume, By Formulation, 2018 - 2031F |
6.1.3 India Erythromycin Market Revenues & Volume, By Gel, 2018 - 2031F |
6.1.4 India Erythromycin Market Revenues & Volume, By Tablet, 2018 - 2031F |
6.1.5 India Erythromycin Market Revenues & Volume, By Topical Solution, 2018 - 2031F |
6.1.6 India Erythromycin Market Revenues & Volume, By Ointment, 2018 - 2031F |
6.1.7 India Erythromycin Market Revenues & Volume, By Others, 2018 - 2031F |
6.2 India Erythromycin Market, By Therapeutic Indications |
6.2.1 Overview and Analysis |
6.2.2 India Erythromycin Market Revenues & Volume, By Respiratory Tract Infections, 2018 - 2031F |
6.2.3 India Erythromycin Market Revenues & Volume, By Eye Infections, 2018 - 2031F |
6.2.4 India Erythromycin Market Revenues & Volume, By Ear Infections, 2018 - 2031F |
6.2.5 India Erythromycin Market Revenues & Volume, By Skin and Soft Tissue Infections, 2018 - 2031F |
6.2.6 India Erythromycin Market Revenues & Volume, By Gastro-intestinal Infections, 2018 - 2031F |
6.2.7 India Erythromycin Market Revenues & Volume, By Others, 2018 - 2031F |
6.3 India Erythromycin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Erythromycin Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2031F |
6.3.3 India Erythromycin Market Revenues & Volume, By Retail Pharmacies, 2018 - 2031F |
6.3.4 India Erythromycin Market Revenues & Volume, By Online Pharmacies, 2018 - 2031F |
7 India Erythromycin Market Import-Export Trade Statistics |
7.1 India Erythromycin Market Export to Major Countries |
7.2 India Erythromycin Market Imports from Major Countries |
8 India Erythromycin Market Key Performance Indicators |
9 India Erythromycin Market - Opportunity Assessment |
9.1 India Erythromycin Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.2 India Erythromycin Market Opportunity Assessment, By Therapeutic Indications, 2021 & 2031F |
9.3 India Erythromycin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Erythromycin Market - Competitive Landscape |
10.1 India Erythromycin Market Revenue Share, By Companies, 2024 |
10.2 India Erythromycin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |